The Management of Heart Failure and the Scope for New Therapies: What Role for Xamoterol?

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.1989.tb03574.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Targeting Myocardial Substrate Metabolism in Heart Failure: Potential for New Therapies

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2012English

Long-Term Studies With Xamoterol in Heart Failure.

British Journal of Clinical Pharmacology
Pharmacology
1989English

Clinical Pharmacological Studies of Xamoterol (Corwin) for Patients With Heart Failure Accompanied With Auricular Fibrillation.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1989English

Calming the Nervous Heart: Autonomic Therapies in Heart Failure

Cardiac Failure Review
2018English

The Role of Pre-Hospital Management in Acute Heart Failure

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

New Management Strategies in Heart Failure

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2016English

The Effects of Age, Sex and Treatment With Xamoterol on Exercise Capacity in Patients With Heart Failure.

British Journal of Clinical Pharmacology
Pharmacology
1989English

Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

The New Heart Failure Association Journal - ESC Heart Failure

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy